The “lactated Ringer versus Albumin in early Sepsis theraPy” (RASP) trial [68] compared 4% albumin solution and lactated Ringer’s in septic cancer patients, finding no significant mortality differences at 7 or 28 days. This evidence concerns the gene ALB and cancer.